Statement: the primary clinical trial presents comprehensive data on the progression-free survival (pfs) of its participants.
Primary_evidence: Outcome Measurement:    Local Control Using Ipsilateral Breast Tumor Recurrence Rates   [Not Specified]   Time frame: 2 years after treatment completion Results 1:    Arm/Group Title: Accelerated Partial Breast Brachytherapy   Arm/Group Description: Each patient will receive accelerated partial breast brachytherapy with multiple plane implant.   Patients will receive 3400 cGy delivered in 10 twice-daily fractions. Treatment is to be given over 5-7 days with a minimum of 6 hours separation between fractions.   Overall Number of Participants Analyzed: 151   Measure Type: Number   Unit of Measure: percentage of participants  .7